Flecainide

Routes
Oral (PO)
Half-Life (t½)
PO: 14h
Formula
C17H20F6N2O3
Molecular Weight
414.34 g/mol
PubChem CID
3356
Aliases
Tambocor

Pharmacological Mechanism

Class IC antiarrhythmic — strong Na+ channel blocker with slow dissociation. "Pill-in-pocket" approach for paroxysmal atrial fibrillation in structurally normal hearts. Pro-arrhythmic in ischemic heart disease (CAST trial 1989) — contraindicated post-MI.

Half-Life & Elimination Curve (PO: 14h)

100%50%25%12.5%0%0h0×t½14h1×t½28h2×t½42h3×t½56h4×t½70h5×t½0×t½ (0h): 100% remaining (~0.189 mg/L)1×t½ (14h): 50% remaining (~94.6 µg/L)2×t½ (28h): 25% remaining (~47.3 µg/L)3×t½ (42h): 12.5% remaining (~23.6 µg/L)4×t½ (56h): 6.3% remaining (~11.8 µg/L)5×t½ (70h): 3.1% remaining (~5.91 µg/L)
Plasma (PO)t½ Decay (14h)
  • 0×t½0h100% (0.189 mg/L)
  • 1×t½14h50% (94.6 µg/L)
  • 2×t½28h25% (47.3 µg/L)
  • 3×t½42h12.5% (23.6 µg/L)
  • 4×t½56h6.3% (11.8 µg/L)
  • 5×t½70h3.1% (5.91 µg/L)
Elimination t½14h (PO)
Rate Constant (ke)0.0495 h⁻¹
Time to Peak (Tmax)4.07h
Est. Peak (Cmax)0.189 mg/L
Clearance (CL)17.3 L/h
97% Washout (5×t½)70h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References